13F HOLDINGS REPORT
Merck & Co., Inc.
Quarter ended Q1 2025 · Filed May 14, 2025 · Accession 0000064978-25-000005
Total Value
$164.3M
Positions
12
Other Managers
1
Confidential Omitted
No
Holdings (12)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MODERNA INC | MRNA | 2,308,190 | $65.4M | 39.83% |
| 2 | PERSONALIS INC | PSNL | 14,044,943 | $49.3M | 30.01% |
| 3 | KYMERA THERAPEUTICS INC | KYMR | 772,165 | $21.1M | 12.86% |
| 4 | ENTRADA THERAPEUTICS INC | TRDA | 1,739,768 | $15.7M | 9.57% |
| 5 | ALECTOR INC | ALEC | 3,545,719 | $4.4M | 2.65% |
| 6 | EVAXION BIOTECH A/S | 29970R204 | 1,214,126 | $2.2M | 1.37% |
| 7 | SUTRO BIOPHARMA INC | STRO | 2,723,509 | $1.8M | 1.08% |
| 8 | LAVA THERAPEUTICS NV | N51517105 | 1,149,345 | $1.5M | 0.89% |
| 9 | VIRIDIAN THERAPEUTICS INC | VRDN | 93,414 | $1.3M | 0.77% |
| 10 | XILIO THERAPEUTICS INC | XLO | 1,483,758 | $1.1M | 0.65% |
| 11 | CARISMA THERAPEUTICS INC | CARM | 1,473,240 | $456,704 | 0.28% |
| 12 | NEUPHORIA THERAPEUTICS INC | NEUP | 10,027 | $57,756 | 0.04% |